Internal link ProQR to Participate in 8th Annual Evercore Healthcare Conference décembre 01, 2025 at 01:00 PM UTC
Internal link ProQR Announces Third Quarter 2025 Operating and Financial Results novembre 06, 2025 at 12:00 PM UTC
Internal link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 octobre 20, 2025 at 12:00 PM UTC
Internal link ProQR to Participate in Upcoming Investor Conferences in October 2025 octobre 13, 2025 at 12:30 PM UTC
Internal link ProQR Announces Second Quarter 2025 Operating and Financial Results août 07, 2025 at 11:00 AM UTC
Internal link ProQR Announces Upcoming Presentation at RNA Editing Summit juillet 28, 2025 at 12:00 PM UTC
Internal link ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP juin 26, 2025 at 08:30 PM UTC
Internal link ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences mai 12, 2025 at 12:00 PM UTC
Internal link ProQR Announces First Quarter 2025 Operating and Financial Results mai 08, 2025 at 11:00 AM UTC
Internal link ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference mai 02, 2025 at 12:00 PM UTC
Internal link ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 mai 01, 2025 at 12:00 PM UTC
Internal link ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth avril 14, 2025 at 11:00 AM UTC
Internal link ProQR Announces Year End 2024 Operating and Financial Results mars 13, 2025 at 11:00 AM UTC
Internal link ProQR Announces R&D Day and Provides Update on Innovation Portfolio novembre 30, 2015 at 12:00 PM UTC
Internal link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials novembre 23, 2015 at 11:30 AM UTC
Internal link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences octobre 01, 2015 at 11:00 AM UTC
Internal link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable septembre 23, 2015 at 11:00 AM UTC
Internal link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment septembre 14, 2015 at 11:00 AM UTC
Internal link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients juin 26, 2015 at 11:54 AM UTC
Internal link ProQR to Present at the JMP Securities Life Science Conference juin 16, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the First Quarter of 2015 mai 21, 2015 at 11:00 AM UTC
Internal link ProQR to Present at Two Upcoming Investor Conferences in May avril 29, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 février 26, 2015 at 12:00 PM UTC